Ashwagandha
Hype is running ahead11,145yearly views per trial paper
Trials exist, but attention is far ahead of the record.
The Copium Meter
Is Ashwagandha copium?
Hype against randomized trials for one topic, computed and dated 30 October 2026. It rates the topic, never a person, and gives no dosing and no sourcing.
The short version
- 680Kyearly wiki viewsEnglish Wikipedia, to 30 Sep 2026
- 61randomized-trial paperstyped on PubMed
- 11,145views per trial paperlower is better backed
- Hype is running aheadthe verdictby the published rule
What does this verdict mean?
English Wikipedia readers opened the Ashwagandha article about 680K times in the year to 30 September 2026. PubMed holds 61 papers typed as randomized trials for it, which is 11,145 yearly views per trial paper. By the published rule that earns the verdict Hype is running ahead.
That is a statement about the gap between attention and trial record. It does not say whether Ashwagandha works or whether it is safe for anyone.
How does it compare with the others?
Ashwagandha next to the other fourhype above, proof below, read 30 October 2026
- BPC-157: Pure copium (308K views, 0 trial papers)
- Tongkat ali: Hype is running ahead (78K views, 6 trial papers)
- Ashwagandha: Hype is running ahead (680K views, 61 trial papers)
- Gua sha: Hype is running ahead (141K views, 16 trial papers)
- Finasteride: Hype is nudging ahead (229K views, 73 trial papers)
- Niacinamide: Hype is nudging ahead (145K views, 52 trial papers)
- Minoxidil: Hype is nudging ahead (299K views, 147 trial papers)
- Retinol: Hype is nudging ahead (140K views, 71 trial papers)
- Collagen: Hype is nudging ahead (232K views, 120 trial papers)
- Creatine: Receipts check out (596K views, 732 trial papers)
- Magnesium: Receipts check out (334K views, 429 trial papers)
- Caffeine: Receipts check out (608K views, 1,021 trial papers)
- Tretinoin: Receipts check out (107K views, 210 trial papers)
- Melatonin: Receipts check out (252K views, 578 trial papers)
- Sunscreen: Receipts check out (131K views, 321 trial papers)
Where do the numbers come from?
- The PubMed search for Ashwagandha papers typed as randomized controlled trials, read 30 October 2026.
- The Wikimedia pageviews tool, for the English article's yearly views.
- This topic was read on 1 November 2026. The attention window is October 2025 to September 2026.
The rule that sorts a ratio into a verdict is on the Meter page and the full method is on how we check.